Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality. LPI (LP Information)' newest research report, the ﾓHuman Oral Vaccine Industry Forecastﾔ looks at past sales and reviews total world Human Oral Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Human Oral Vaccine sales for 2023 through 2029. With Human Oral Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Oral Vaccine industry. This Insight Report provides a comprehensive analysis of the global Human Oral Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Oral Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Human Oral Vaccine market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Oral Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Oral Vaccine. The global Human Oral Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029. United States market for Human Oral Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. China market for Human Oral Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. Europe market for Human Oral Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. Global key Human Oral Vaccine players cover Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022. This report presents a comprehensive overview, market shares, and growth opportunities of Human Oral Vaccine market by product type, application, key manufacturers and key regions and countries. Market Segmentation: Segmentation by type Rotavirus Vaccine Cholera Vaccine Oral Polio Vaccine Other Segmentation by application Public Private This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Merck GSK Sanofi Lanzhou Institute Serum Institute Valneva Shanghai United Cell Bibcol PaxVax Vabiotech Tiantan Biological EuBiologics Panacea Biotec Ltd Bio-Med Halfkin Bio-Pharmaceuticals Key Questions Addressed in this Report What is the 10-year outlook for the global Human Oral Vaccine market? What factors are driving Human Oral Vaccine market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Human Oral Vaccine market opportunities vary by end market size? How does Human Oral Vaccine break out type, application? What are the influences of COVID-19 and Russia-Ukraine war?
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Human Oral Vaccine Annual Sales 2018-2029 2.1.2 Wor
